There won’t be any college kids on Humana’s five main campuses around the country this summer. Their summer intern program is going virtual. …read more […]
Shares in Gilead Sciences (GILD) fell 5% in Friday’s trading after the company’s first quarter earnings results sparked a wave of downgrades from the Street. JP Morgan and Raymond James downgraded the stock from Buy to Hold on May 1, while SunTrust Robinson went one step further- taking its GILD rating from Hold to Sell due to “lack of visibility to growth.”“All guidance has been withdrawn due in part to uncertainty around COVID-19 impact on the core business, but primarily due to unknown revenue and costs with remdesivir [Gilead’s antiviral drug for the treatment of COVID-19]. We believe investors should …read more […]
Shares in Boeing Co (BA) fell after the ailing planemaker said it raised $25 billion in debt financing and told investors that as a result it would not need to tap capital markets or the U.S. government for additional funding for now.The planemaker’s stock dropped 5.4% to $133.37 in U.S. trading on Friday, taking its year-to-date plunge to 60%. The bond offering included debt instruments with an aggregate principal amount of $25 billion across seven tranches with maturities ranging from three to 40 years.“The robust demand for the offering reflects strong support for the long-term strength of Boeing and the …read more […]
Gilead Sciences (GILD) has announced that its remdesivir drug has received emergency FDA approval for the treatment of severe cases of Covid-19.“It is reasonable to believe that the known and potential benefits of RDV outweigh the known and potential risks of the drug for the treatment of patients hospitalized with severe COVID-19” the FDA wrote in its approval letter to Gilead.The decision was based on review of the topline data from the randomized, double-blinded, placebo-controlled trial conducted by The National Institute of Allergy and Infectious Diseases (NIAID) and from the Gilead-sponsored open-label trial that evaluated different durations of remdesivir.Following the …read more […]
Apple (AAPL) has reported solid earnings results for its fiscal second quarter with Q2 GAAP EPS of $2.55 beating consensus expectations by $0.29. Revenue of $58.31B came in marginally higher year-over-year, smashing the Street’s forecast by $3.67B. International sales accounted for 62% of the quarter’s revenue.Crucially, AAPL also reported that its install base of active users reached an all-time high in all geographic segments as well as all major product categories. “Despite COVID-19’s unprecedented global impact, we’re proud to report that Apple grew for the quarter, driven by an all-time record in Services and a quarterly record for Wearables,” commented …read more […]
(Bloomberg) — Even a calamity of disease, death and economic destruction afflicting the world all at once isn’t enough to suppress the notion in some quarters that inflation could return with a vengeance.The coronavirus crisis has killed hundreds of thousands, incapacitated millions and affected the livelihoods of billions — prompting policy makers to fear a deflation spiral reminiscent of the Great Depression. But economists including former Bank of England official Charles Goodhart, and investors such as BNP Paribas Asset Management, are asking if a different phenomenon lurks in the wreckage of global growth.Such contrarians wonder if an environment of ultra-loose …read more […]
Governments, businesses and individuals are seeking such blood tests, to help them learn more about who may have had the disease, who may have some immunity and to potentially craft strategies to end lockdowns that have battered global economies. Roche had previously pledged to make its antibody test available by early May and to boost production by June to “high double-digit millions” per month. The Basel-based company, which also makes separate molecular tests to identify people with active COVID-19 infections, said its antibody test, Elecsys Anti-SARS-CoV-2, has a specificity rate of about 99.8% and sensitivity rate of 100%. …read more […]
Roche Holding AG received emergency use approval from the U.S. Food and Drug Administration (FDA) for an antibody test to help determine if people have ever been infected with the coronavirus, the Swiss drugmaker said http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20200503:nGNE71pdqt on Sunday.
(Bloomberg) — U.S. daily coronavirus cases rose faster than the one-week average, with New York adding another 4,663 cases and Texas reporting its biggest one-day rise. New York City’s mayor reiterated a call for federal financial aid as the state’s governor said new deaths were higher.U.K. fatalities neared the toll for Italy, which reported a jump that kept its tally the highest in Europe.Warren Buffett said Berkshire Hathaway has sold its entire stake in four major airlines as a result of the economic fallout from the virus. The Philippines halted all commercial flights starting Sunday.Australia continued to relax curbs, with …read more […]
(Bloomberg) — Once again, when stocks rally, it’s Europe that’s left behind.With the S&P 500 about 30% above its March lows, the Stoxx 600 index has lagged behind with a 21% bounce, despite having fallen more than the U.S. in the global selloff sparked by the coronavirus pandemic.The reason? For starters, there’s the market’s makeup: Europe has a large presence of cyclical sectors, such as banks and energy, which have underperformed during this crisis. On top of that, the region has led the recent wave of dividend cuts by major companies. Investors have also been disappointed by the scale of …read more […]
The ongoing U.S. travel crisis is causing thousands of job cuts as the aviation sector waits for passengers to return to the skies but braces for years of lower demand because of the coronavirus pandemic. U.S. airlines are slashing hundreds of thousands of flights, cutting schedules by 80% or more through at least June and parking thousands of jets as demand for tickets has plunged by about 95%. Airlines are requiring facial coverings and implementing new cleaning procedures to try to convince passengers it is safe to fly again, but also fear the weakened economy may further drag …read more […]
Roche Holding AG received emergency use approval from the U.S. Food and Drug Administration for an antibody test to help determine if people have ever been infected with the coronavirus, the Swiss drugmaker said http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20200503:nGNE71pdqt on Sunday.
Governments, businesses and individuals are seeking such blood tests, to help them learn more about who may have had the disease, who may have some immunity and to potentially craft strategies to end lockdowns that have battered global economies. Roche had previously pledged to make its antibody test available by early May and to boost production by June to “high double-digit millions” per month. The Basel-based company, which also makes separate molecular tests to identify people with active COVID-19 infections, said its antibody test, Elecsys Anti-SARS-CoV-2, has a specificity rate of about 99.8% and sensitivity rate of 100%. …read more […]
Billionaire investor Warren Buffett on Saturday said the United States’ capacity to withstand crises provides a silver lining as it combats the coronavirus, even as he acknowledged that the global pandemic could significantly damage the economy and his investments.
The conglomerate had held sizeable positions in the airlines, including an 11% stake in Delta Air Lines, 10% of American Airlines Co, 10% of Southwest Airlines Co and 9% of United Airlines at the end of 2019, according to its annual report and company filings. Buffett said the airline industry’s outlook rapidly changed. Berkshire disclosed on April 3 it had sold about 18% of its Delta stake and 4% of its Southwest shares. …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
